Artiva Biotherapeutics (ARTV) Retained Earnings (2023 - 2026)
Artiva Biotherapeutics (ARTV) reported Retained Earnings of -$354.1 million for Q1 2026, down 32.61% year-over-year from -$525.4 million in Q1 2025, and down 7.11% quarter-over-quarter from -$330.5 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Retained Earnings (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Retained Earnings data on file, last reported at -$354.1 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$354.1 million, down 32.61% year-over-year; the trailing twelve-month figure through Mar 2026 was -$354.1 million (down 32.61% YoY), and the FY2025 annual result was -$330.5 million, down 34.0% from the prior year.
- Retained Earnings declined to -$354.1 million in Q1 2026 per ARTV's latest filing, from -$330.5 million in the prior quarter.
- Over five years, Retained Earnings peaked at $121000.0 in Q2 2024 and troughed at -$354.1 million in Q1 2026.
- A 4-year average of -$245.3 million and a median of -$267.0 million in 2025 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings plunged 238281.82% in 2025, then sank 32.61% in 2026.
- A 4-year view of Retained Earnings shows it stood at -$181.3 million in 2023, then slumped by 36.06% to -$246.7 million in 2024, then plunged by 34.0% to -$330.5 million in 2025, then declined by 7.11% to -$354.1 million in 2026.
- Business Quant data shows ARTV's Retained Earnings at -$354.1 million in Q1 2026, -$330.5 million in Q4 2025, and -$309.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - | -354.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -354.07 Mn |
| Dec 31, 2025 | -330.55 Mn |
| Sep 30, 2025 | -309.80 Mn |
| Jun 30, 2025 | -288.20 Mn |
| Mar 31, 2025 | -267.00 Mn |
| Dec 31, 2024 | -246.68 Mn |
| Sep 30, 2024 | -230.59 Mn |
| Jun 30, 2024 | 121,000.00 |
| Dec 31, 2023 | -181.31 Mn |